Evidence Supports Buprenorphine for Acute Pain in Patients with Opioid Use Disorder
Continuing buprenorphine during acute pain episodes for people with opioid use disorder (OUD) may lead to lower or similar pain severity compared to discontinuation.
Category: Other Chronic Diseases
Other Chronic Diseases
Latest
Evidence Supports Buprenorphine for Acute Pain in Patients with Opioid Use Disorder
Continuing buprenorphine during acute pain episodes for people with opioid use disorder (OUD) may lead to lower or similar pain severity compared to discontinuation.
Read More
Infant Exposure to Higher Ozone Levels Tied to Child Asthma, Wheeze
Children exposed to higher levels of ozone in their first two years of life were significantly more likely to be diagnosed with asthma or wheezing at ages 4-6.
Read More
Future NBA Hall of Famer Sidelined by DVT
An NBA all-star for the Milwaukee Bucks will miss the remainder of the NBA regular season after being diagnosed with deep vein thrombosis (DVT).
Read More
New Genetic Target for Sickle Cell Disease Treatment
Researchers have identified a potential new gene target that could be edited to treat sickle cell disease.
Read More
Company to Deploy Gene Editing for Alpha-1 Disease
Prime Medical will use its gene editing platform to correct the gene mutations that lead to alpha-1 antitrypsin deficiency (AATD) lung disease and liver disease.
Read More
Lower Cardiovascular Risks for Vapers with HIV Compared to Smokers with HIV
Vaping may have lower cardiovascular risks than cigarette smoking in patients with HIV, new JAHA research reports.
Read More
Global Warming Can Lead to Inflammation in Human Airways
Dry air caused by global warming may exacerbate airway dehydration, increasing the risk of inflammation-related conditions like asthma and chronic cough.
Read More
3D Printed Airway for Tracheobronchomalacia Begins Clinical Trials
A first-of-its-kind 3D-printed bioresorbable airway splint intended to help children with severe tracheobronchomalacia will begin clinical trials to assess its safety and therapeutic value.
Read More
Bronchiectasis and NTM Establishes Care Center Network with 33 Sites
Twenty-seven health centers have been added to the new Bronchiectasis and NTM Care Center Network, along with six clinical associate center sites.
Read More
FDA Approves Biosimilar Omlyclo for Asthma
Omlyclo (omalizumab-igec) is the first and only biosimilar designated as interchangeable with Xolair (omalizumab) for the treatment of moderate to severe persistent asthma, CRSwNP, IgE-mediated food allergy, and chronic spontaneous urticaria.
Read More
Mepolizumab Reduced Need for Repeat Sinus Surgeries in CRwNP Patients
Patients using mepolizumab (Nucala) experienced significant improvement in nasal polyps, nasal obstruction, smell and overall symptoms.
Read More
Tezspire Significantly Reduced Nasal Congestion, Polyp Size in CRwNP Patients
Tezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.
Read More
Novel Bone Marrow Transplant Can Cure Sickle Cell Disease
A novel transplant procedure using bone marrow from a “half-matched” donor is safe and curative for adults with sickle cell disease, as well as more affordable than recently approved gene therapy products for SCD.
Read More
Bronchiectasis and NTM 360 Gets a Rebrand
The Bronchiectasis and NTM Association will continued the organization’s growth as a leader in advancing care, research, and awareness of bronchiectasis and NTM lung disease.
Read More
NBA Star Victor Wembanyama Diagnosed with DVT
The San Antonio Spurs report center Victor Wembanyama has been diagnosed with deep vein thrombosis (DVT) in his shoulder and will miss the rest of the NBA’s regular season.
Read More
mRNA Therapy Could Repair Damaged Lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to UPenn researchers.
Read More
Cases of ME/CFS Increase Following COVID-19
COVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Read More
Steroids Prior to Preterm Birth May Improve Lung, Placental Function
A first-of-its-kind study examined parallel lung and placental changes in response to prenatal steroids.
Read More
Sickle Cell Disease Tied to Older-Looking Brains
Researchers found that participants with sickle cell disease had brains that appeared an average of 14 years older than their actual age.
Read More
Investigational Brensocatib Reduces Exacerbations Across Most Bronchiectasis Subgroups
New sub-analyses show that brensocatib reduced pulmonary exacerbations and slowed lung function decline for most subgroups of patients with non-cystic fibrosis bronchiectasis.
Read More
FDA Approves Dupixent for Chronic Rhinosinusitis with Nasal Polyps in Adolescents
The FDA has approved Dupixent as an add-on maintenance treatment for adolescents aged 12-17 with chronic rhinosinusitis with nasal polyps, expanding its original approval for adults in 2019.
Read More
Milder Blood Stem Cell Transplants Preserves Lung Function in Sickle Cell Patients
An NIH study found that lung function remained stable or improved after patients with sickle cell disease underwent low-intensity blood stem cell transplants.
Read More
Does Chronic Cough Run in the Family? Study Suggests Genetic Link
Researchers found that children of parents with chronic dry cough are over 50% more likely to develop it themselves.
Read More
World Bronchiectasis Day Observed July 1st
World Bronchiectasis Day (July 1) was established in 2022 to raise awareness of bronchiectasis and its increased prevalence in many countries.
Read More